title: Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis.
abstract: Parathyroid hormone-related protein (PTHrP) was initially recognized for its ability to promote parathyroid hormone-like bioactivity in kidney, bone, and squamous epithelial cells. PTHrP is a multifunctional protein in which bioactivity is mediated by two distinct pathways. Its classic parathyroid hormone-like activity results from binding of its amino terminus to cell surface PTH1R and activation of signal transduction pathways. Another less well recognized pathway involves translocation of PTHrP to the nucleus via a mid-region bipartite nuclear targeting sequence (NTS), similar in structure and function to those found in retroviral regulatory proteins. PTHrP was identified in the nucleus of several different cell types in vivo and in vitro, where it has been implicated in cell cycle progression, cellular differentiation, and apoptosis. In previous work we showed that nuclear translocation of PTHrP enhanced the survival of serum-deprived chondrogenic cells, associated with RNA, and localized to a region of the nucleus rich in complexes of newly transcribed ribosomal RNA and protein. In this work we have used two chondrogenic cell lines, CFK2 (PTH1R+) and 27m21 (PTH1R-) to further explore mechanisms whereby PTHrP rescues immature chondrocytes from apoptosis. Endogenous PTHrP and exogenous PTHrP NTS peptide protected serum-deprived cells from apoptosis, in the presence and absence of PTH1R. The survival of cells expressing PTHrP and those treated with PTHrP NTS peptide was associated with a rapid shift into G(o)/G1 accompanied by a significant down-regulation of rRNA synthesis and a decrease in the number of actively translating polyribosome complexes. Together with our previous observations, this work predicts a role for PTHrP in modulating ribosome biogenesis and preventing chondrogenic cells from progressing through the cell cycle in an unfavorable environment.
authors.affiliation: Department of Medicine, McGill University, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Québec H3T 1E2, Canada.
authors.forename: M M
authors.initials: MM
authors.lastname: Aarts
authors.forename: D
authors.initials: D
authors.lastname: Davidson
authors.forename: A
authors.initials: A
authors.lastname: Corluka
authors.forename: E
authors.initials: E
authors.lastname: Petroulakis
authors.forename: J
authors.initials: J
authors.lastname: Guo
authors.forename: F R
authors.initials: FR
authors.lastname: Bringhurst
authors.forename: J
authors.initials: J
authors.lastname: Galipeau
authors.forename: J E
authors.initials: JE
authors.lastname: Henderson
mesh_terms: D001483:Base Sequence; D002453:Cell Cycle; D002470:Cell Survival / Q000502:physiology*; D019902:Chondrocytes / Q000166:cytology*; D016895:Culture Media, Serum-Free; D017931:DNA Primers; D005434:Flow Cytometry; D044162:Parathyroid Hormone-Related Protein; D014176:Protein Biosynthesis / Q000502:physiology; D011506:Proteins / Q000502:physiology*; D012335:RNA, Ribosomal / Q000096:biosynthesis*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D016895:Culture Media, Serum-Free; D017931:DNA Primers; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D012335:RNA, Ribosomal